- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05365165
Researching the Affect of Sevoflurane in Cardiac Surgery on Delirium
May 5, 2022 updated by: Aysegul Cigdem Caglayan, Derince Training and Research Hospital
Researching the Affect of Sevoflurane Application for Maintenance of Anesthesia During Aortic Cross-clamping in Cardiac Surgery on Delirium
Many risk factors have been identified for delirium after open heart surgery .
One of the main risk factors; duration of stay on mechanical ventilator .
Our hypothesis; The use of sevoflurane during aortic cross-clamping reduces the need for long-acting intravenous anesthetic agents.
Therefore, patients will be weaned from the mechanical ventilator in a shorter time.
Patients with shorter stays on mechanical ventilation develop less postoperative delirium.
Study Overview
Detailed Description
Standard anesthesia management will be applied in the induction and maintenance of anesthesia.
In the induction of anesthesia 1mg/kg lidocaine , 1.5-2mg/kg propofol , 1 mcg /kg fentanyl citrate, 0.6 mg/kg rocuronium bromide will be administered.
Sevoflurane for maintenance of anesthesia and propofol and fentanyl if needed bolus will be applied.
BIS monitoring will be performed to control the depth of anesthesia.
Patients' peroperative hemodynamic levels, arterial blood gas levels, operation time, pump time, aortic cross clamp time, postoperative complications , the amount of blood and fluid used, the amount of iv anesthetic used, the extubation time, the length of stay in the intensive care unit, the length of stay in the hospital will be followed and recorded.
Postoperative delirium follow-ups of the patients will be recorded once a day by the same investigator using the Nursing Delirium Screening Scale and Delirium Rating Scale Revised-98 until they are discharged from the hospital .
Study Type
Observational
Enrollment (Anticipated)
2
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Mehmet Yılmaz
- Phone Number: +902623178000
- Email: drmyilmaz33@gmail.com
Study Locations
-
-
-
Kocaeli, Turkey
- Recruiting
- Ayşegül Çiğdem Çağlayan
-
Contact:
- çiğdem çağlayan
- Phone Number: +905055347107
- Email: cigdemxyalcin@gmail.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Patients who will have elective open heart surgery, patients over the age of 18, and patients with a score of 25 and above in the mini mental state test performed in the preoperative period will be included in the study.
Description
Inclusion Criteria:
Patients with a score of 25 and above in the mini-mental state test performed in the preoperative period
Exclusion Criteria:
Those who are scheduled for emergency surgery
Those with known dementia and/or neurological disease
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
sevoflurane
Standard anesthesia management will be applied in the induction and maintenance of anesthesia.
In the induction of anesthesia 1mg/kg lidocaine , 1.5-2mg/kg propofol , 1 mcg /kg fentanyl citrate, 0.6 mg/kg rocuronium bromide will be administered.
Sevoflurane for maintenance of anesthesia and propofol and fentanyl if needed bolus will be applied.
BIS monitoring will be performed to control the depth of anesthesia.
|
Sevoflurane will be applied during aortic cross- clamping in cardiac surgery
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
rate of delirium after open heart surgery
Time Frame: up to 2 weeks
|
Postoperative delirium follow-ups of the patients will be recorded once a day by the same investigator using the Nursing Delirium Screening Scale and Delirium Rating Scale Revised-98 until they are discharged from the hospital.
The Nu-DESC is a 5-item observation scale that can be completed quickly.
Each item is evaluated on a 3-point Likert (from 0 to 3).
The total score is obtained by adding the values of the items, and the highest score is 10.
If the total score is 2 and above, the diagnosed of delirium is made.
The DRS-R-98 is a 16-item scale with a maximum total scale score of 46 points and a maximum severity score of 39 points.
A suggested cut-off score for delirium is >19 points.
|
up to 2 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 15, 2022
Primary Completion (Anticipated)
August 1, 2022
Study Completion (Anticipated)
October 1, 2022
Study Registration Dates
First Submitted
April 24, 2022
First Submitted That Met QC Criteria
May 5, 2022
First Posted (Actual)
May 9, 2022
Study Record Updates
Last Update Posted (Actual)
May 9, 2022
Last Update Submitted That Met QC Criteria
May 5, 2022
Last Verified
May 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Mental Disorders
- Nervous System Diseases
- Neurologic Manifestations
- Confusion
- Neurobehavioral Manifestations
- Neurocognitive Disorders
- Delirium
- Physiological Effects of Drugs
- Central Nervous System Depressants
- Anesthetics, General
- Anesthetics
- Platelet Aggregation Inhibitors
- Anesthetics, Inhalation
- Sevoflurane
Other Study ID Numbers
- DERINCETRHCCAGLAYAN002
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.